All Stories

  1. In memoriam Prof. Pawel P. Liberski, MD PhD (November 25, 1954–August 19, 2025)
  2. Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence
  3. Histotype-Dependent Oligodendroglial PrP Pathology in Sporadic CJD: A Frequent Feature of the M2C “Strain”
  4. Greenfield's Neuropathology - Two Volume Set
  5. Distinctive cerebral neuropathology in an adult case of sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) syndrome
  6. K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution
  7. Iatrogenic Creutzfeldt–Jakob disease
  8. Phenotypic and functional complexity of brain-infiltrating T cells in Rasmussen encephalitis
  9. Comorbidity and prognosis in disproportionately enlarged subarachnoid space hydrocephalus (DESH-iNPH): Japanese and Austrian cohort studies
  10. Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG)
  11. SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda's legacy and future directions
  12. Cystatin F is a biomarker of prion pathogenesis in mice
  13. Fatal childhood hypertension
  14. Tau pathology in Creutzfeldt-Jakob disease revisited
  15. Neuropathological criteria of anti-IgLON5-related tauopathy
  16. Prion diseases
  17. Prion 2016 Oral Abstracts
  18. Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant
  19. Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting
  20. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
  21. The end of the BSE saga: do we still need surveillance for human prion diseases?
  22. Iatrogenic and sporadic Creutzfeldt-Jakob disease in 2 sisters without mutation in the prion protein gene
  23. Structure-based drug design identifies polythiophenes as antiprion compounds
  24. Molecular Genetics of Creutzfeldt-Jakob Disease and Gerstmann- Sträussler- Scheinker Disease
  25. A Genome Wide Association Study Links Glutamate Receptor Pathway to Sporadic Creutzfeldt-Jakob Disease Risk
  26. Reduction in Serum Aquaporin-4 Antibody Titers During Development of a Tumor-Like Brain Lesion in a Patient With Neuromyelitis Optica: A Serum Antibody–Consuming Effect?
  27. A case of variably protease-sensitive prionopathy treated with doxycyclin
  28. The Role of the NADPH Oxidase NOX2 in Prion Pathogenesis
  29. MRI features of Binswanger's disease predict prognosis and associated pathology
  30. Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread
  31. Disproportionate subarachnoid space hydrocephalus—outcome and perivascular space
  32. ISN Information Days at the University of Witwatersrand Medical School, Johannesburg (South Africa) on September 23rd-24th, 2013
  33. Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?
  34. Prion diseases: an introduction
  35. JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment
  36. Globular glial tauopathies (GGT): consensus recommendations
  37. Intensity of human prion disease surveillance predicts observed disease incidence
  38. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series
  39. Imported human rabies in Switzerland, 2012: A diagnostic conundrum
  40. Cerebellar dysfunction in a family harboring the PSEN1 mutation co-segregating with a Cathepsin D variant p.A58V
  41. Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium
  42. Neuropathology
  43. Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis
  44. External granular cell layer bobbling: a distinct histomorphological feature of the developing human cerebellum
  45. Gerstmann–Sträussler–Scheinker Disease
  46. The need to unify neuropathological assessments of vascular alterations in the ageing brain
  47. The Spectrum of Tau Pathology in Human Prion Disease
  48. Risk assessment of biological hazards for consumer protection
  49. Stabilization of a Prion Strain of Synthetic Origin Requires Multiple Serial Passages
  50. Scientific Opinion on Reflecting on the experiences and lessons learnt from modelling on biological hazards
  51. Scientific Opinion on the development of a risk ranking framework on biological hazards
  52. Obituary: In Memoriam: Professor John Daniel Collins
  53. Scientific Opinion on a review on the European Union Summary Reports on trends and sources zoonoses, zoonotic agents and food‐borne outbreaks in 2009 and 2010 – specifically for the data on Salmonella, Campylobacter, verotoxigenic Escherichia coli, Lis...
  54. A New Mechanism for Transmissible Prion Diseases
  55. Scientific Opinion on Public health risks represented by certain composite products containing food of animal origin
  56. Scientific Opinion on the evaluation of new TSE rapid tests submitted in the framework of the Commission Call for expression of interest 2007/S204-247339
  57. Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone
  58. Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection
  59. Antibody 9D5 Recognizes Oligomeric Pyroglutamate Amyloid-β in a Fraction of Amyloid-β Deposits in Alzheimer's Disease without Cross-Reactivity with other Protein Aggregates
  60. Novel crystalloid oligodendrogliopathy in hereditary spastic paraplegia
  61. Scientific Opinion on the minimum hygiene criteria to be applied to clean seawater and on the public health risks and hygiene criteria for bottled seawater intended for domestic use
  62. Statement on a request from the European Commission for the assessment of the scientific elements supporting the prohibition for the placing on the market of GM potato EH92‐527‐1 for cultivation purposes in Austria
  63. Intraneuronal Immunoreactivity for the Prion Protein Distinguishes a Subset of E200K Genetic From Sporadic Creutzfeldt-Jakob Disease
  64. Advocacy for Neuropathology in practice: ISN Information Days
  65. An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology
  66. Scientific Opinion on Composting and incineration of dead-on-farm pigs
  67. Asymmetry of neurodegenerative disease-related pathologies: a cautionary note
  68. Scientific Opinion on Norovirus (NoV) in oysters: methods, limits and control options
  69. Scientific Opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2011 update)
  70. Genesis of Mammalian Prions: From Non-infectious Amyloid Fibrils to a Transmissible Prion Disease
  71. Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease
  72. Scientific Opinion on On-site treatment of pig carcasses
  73. Scientific Opinion on Isolation in proofed pit on-farm of dead poultry
  74. Multiple intracranial cavernomas with focal amyloid deposition – diagnostic pitfalls
  75. Scientific Opinion on the public health hazards to be covered by inspection of meat (swine)
  76. Scientific Opinion on risk based control of biogenic amine formation in fermented foods
  77. Sporadic Creutzfeldt-Jakob Disease
  78. Complex tauopathies vs. tangle predominant dementia
  79. Editorial: The European Response to BSE: A Success Story
  80. Scientific Opinion on the evaluation of a new processing method for ABP Category 2 materials of fish origin
  81. Advocacy for Neuropathology
  82. Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals
  83. Scientific Opinion on assessment of epidemiological data in relation to the health risks resulting from the presence of parasites in wild caught fish from fishing grounds in the Baltic Sea
  84. Scientific Opinion on a quantitative estimation of the public health impact of setting a new target for the reduction of Salmonella in broilers
  85. Scientific Opinion on Hatchery Waste as animal by‐products
  86. Long-term clinical improvement of progressive multifocal leukoencephalopathy associated with prominent inflammatory response and follicular lymphoma
  87. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
  88. Scientific Opinion on a summary of scientific studies undertaken by the UK Food Standards Agency to support a proposed production method for smoked “skin-on” sheep meat
  89. Peroxisomal alterations in Alzheimer’s disease
  90. Fibulin-5 mutations link inherited neuropathies, age-related macular degeneration and hyperelastic skin
  91. Scientific Opinion onCampylobacterin broiler meat production: control options and performance objectives and/or targets at different stages of the food chain
  92. Scientific Opinion on the efficacy and microbiological safety of irradiation of food
  93. New lexicon and criteria for the diagnosis of Alzheimer's disease
  94. Compassion for our colleagues and friends in Japan
  95. A peculiar constellation of tau pathology defines a subset of dementia in the elderly
  96. Scientific Opinion on a review of the BSE-related risk in bovine intestines
  97. Joint Scientific Opinion on any possible epidemiological or molecular association between TSEs in animals and humans
  98. Scientific Opinion on the revision of the quantitative risk assessment (QRA) of the BSE risk posed by processed animal proteins (PAPs)
  99. Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7
  100. Prediction of Preadolescent Depressive Symptoms From Child Temperament, Maternal Distress, and Gender: Results of a Prospective, Longitudinal Study
  101. Post-Salzburg Blues vs. Rise to New Horizons?
  102. Scientific Opinion on BSE/TSE infectivity in small ruminant tissues
  103. Scientific Opinion on a second update on the risk for human and animal health related to the revision of the BSE monitoring regime in some Member States
  104. Scientific Opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2010 update)
  105. Ultrastructural Characteristics (or Evaluation) of Creutzfeldt-Jakob Disease and Other Human Transmissible Spongiform Encephalopathies or Prion Diseases
  106. Scientific Opinion on the results of the EU survey for Chronic Wasting Disease (CWD) in cervids
  107. Scientific Opinion on Fish Oil for Human Consumption. Food Hygiene, including Rancidity
  108. Scientific Opinion on monitoring and assessment of the public health risk of “SalmonellaTyphimurium-like” strains
  109. Scientific Opinion on the Neste Oil Application for a new alternative method of disposal or use of Animal By-Products
  110. Peroxisomal Localization of the Proopiomelanocortin-Derived Peptides β-Lipotropin and β-Endorphin
  111. Viral Meningo-Encephalitis
  112. Scientific Opinion on the safety and efficacy of using recycled hot water as a decontamination technique for meat carcasses
  113. Increased neuronal Rab5 immunoreactive endosomes do not colocalize with TDP-43 in motor neuron disease
  114. Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases
  115. Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis
  116. Welcome to ICN 2010
  117. Scientific Opinion on Lime Treatment of Solid Pig and Poultry Manure
  118. Statement on technical assistance on the format for applications for new alternative methods for animal by‐products
  119. Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy
  120. Statement on Food safety considerations of novel H1N1 influenza virus infections in humans
  121. Prion Diseases
  122. Subacute and Chronic Viral Infections
  123. Scientific Opinion on Q fever
  124. Scientific Opinion on risk assessment of parasites in fishery products
  125. Scientific Opinion on a quantitative estimation of the public health impact of setting a new target for the reduction of Salmonella in laying hens
  126. Scientific Opinion on a Quantitative Microbiological Risk Assessment of Salmonella in slaughter and breeder pigs
  127. Scientific Opinion on Analytical sensitivity of approved TSE rapid tests – new data for assessment of two rapid tests
  128. Distribution of apoptosis-related proteins in sporadic Creutzfeldt–Jakob disease
  129. Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics
  130. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management
  131. Scientific Opinion on the link between Salmonella criteria at different stages of the poultry production chain
  132. Status of ICN 2010
  133. Recombinant prion protein induces a new transmissible prion disease in wild-type animals
  134. Scientific Opinion on Quantification of the risk posed by broiler meat to human campylobacteriosis in the EU
  135. Cathepsin D (C224T) Polymorphism in Sporadic and Genetic Creutzfeldt-Jakob Disease
  136. Genetic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease
  137. In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases
  138. No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome
  139. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea
  140. Danon disease: Case report and detection of new mutation
  141. Inter-Laboratory Assessment of PrPScTyping in Creutzfeldt-Jakob Disease: A Western Blot Study within the NeuroPrion Consortium
  142. S1‐02‐05: Reproducibility in the assessment of Alzheimer's disease and Lewy body disease‐related pathologies: A study by Brain Net Europe
  143. Molecular Pathology of Human Prion Diseases
  144. Reduced Expression of Excitatory Amino Acid Transporter 2 and Diffuse Microglial Activation in the Cerebral Cortex in AIDS Cases With or Without HIV Encephalitis
  145. Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease
  146. The maintenance of the list of QPS microorganisms intentionally added to food or feed - Scientific Opinion of the Panel on Biological Hazards
  147. Prospective challenges facing the EFSA Biological Hazards Panel Report of the Panel on Biological Hazards
  148. Food Safety considerations of animal welfare aspects of husbandry systems for farmed fish - Scientific opinion of the Panel on Biological Hazards
  149. BSE and TSEs: Past, present and future
  150. Accumulation of HtrA2/Omi in Neuronal and Glial Inclusions in Brains With α-Synucleinopathies
  151. White Matter Tauopathy With Globular Glial Inclusions: A Distinct Sporadic Frontotemporal Lobar Degeneration
  152. Excretion of Transmissible Spongiform Encephalopathy Infectivity in Urine
  153. Nigral burden of α-synuclein correlates with striatal dopamine deficit
  154. The role of parvalbumin and calbindin D28k in experimental scrapie
  155. Overview of methods for source attribution for human illness from food‐borne microbiological hazards ‐ Scientific Opinion of the Panel on Biological Hazards
  156. Risk for Human and Animal Health related to the revision of the BSE Monitoring regime in some Member States ‐ Scientific Opinion
  157. Further consideration of age‐related parameters on the Risk for Human and Animal Health related to the revision of the BSE Monitoring regime in some Member States
  158. Endothelial and Myogenic Differentiation of Hematopoietic Progenitor Cells in Inflammatory Myopathies
  159. Intrathecal anti-αB-crystallin IgG antibody responses: Potential inflammatory markers in Guillain-Barré syndrome
  160. Assessment of the possible effect of the four antimicrobial treatment substances on the emergence of antimicrobial resistance - Scientific Opinion of the Panel on Biological Hazards
  161. Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome
  162. Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium
  163. Inter-laboratory comparison of neuropathological assessments of β-amyloid protein: a study of the BrainNet Europe consortium
  164. Prion Diseases: From Protein to Cell Pathology
  165. Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases
  166. Assessment of α-Synuclein Pathology: A Study of the BrainNet Europe Consortium
  167. A quantitative microbiological risk assessment on Salmonella in meat : Source attribution for human salmonellosis from meat - Scientific Opinion of the Panel on Biological Hazards
  168. Biological Safety of a Process for the Hydrolysis on-Farm of Dead Pigs - Scientific Opinion of the Panel on Biological Hazards
  169. Biological Safety of a Process for the Hydrolysis on-Farm of Dead Rabbits - Scientific Opinion of the Panel on Biological Hazards
  170. Scientific and technical clarification in the interpretation and consideration of some facets of the conclusions of its Opinion of 8 March 2007 on certain aspects related to the risk of Transmissible Spongiform Encephalopathies (TSEs) in ovine and capr...
  171. Iatrogenic Creutzfeldt Jakob disease 22 years after human growth hormone therapy: clinical and radiological features
  172. Franz Seitelberger (4 December 1916 to 2 November 2007)
  173. Creutzfeldt-Jakob Disease in Austria: An Autopsy-Controlled Study
  174. Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience
  175. DEAR READER
  176. Surveillance and monitoring of Toxoplasma in humans, food and animals - Scientific Opinion of the Panel on Biological Hazards
  177. Monitoring and identification of human enteropathogenic Yersinia spp. - Scientific Opinion of the Panel on Biological Hazards
  178. Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: Implications for X-linked adrenoleukodystrophy
  179. Scientific Opinion of the Panel on Biological Hazards: Protocol for a preliminary evaluation of ante-mortem TSE tests for ruminants
  180. Verbal perseveration as the initial symptom in a case of Creutzfeldt‐Jakob disease
  181. Papillary glioneuronal tumor
  182. Bilateral striopallidodentate calcification (Fahr's syndrome) and multiple system atrophy in a patient with longstanding hypoparathyroidism
  183. Fatal Neurological Disease in Scrapie-Infected Mice Induced for Experimental Autoimmune Encephalomyelitis
  184. Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study
  185. Errata
  186. Involvement of the Endosomal-Lysosomal System Correlates With Regional Pathology in Creutzfeldt-Jakob Disease
  187. Immunohistochemical detection of class III ?-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker
  188. Tickborne Encephalitis in Naturally Exposed Monkey (Macaca sylvanus)
  189. Autopsy at 2 months after death: Brain is satisfactorily preserved for neuropathology
  190. Fulminant central nervous system demyelination associated with interferon-α therapy and hepatitis C virus infection
  191. Malignant predominantly minigemistocytic glioma in two infants: a distinctive glioma variant?
  192. Secretagogin expression in tumours of the human brain and its coverings
  193. Accumulation of Hsc70 and Hsp70 in glial cytoplasmic inclusions in patients with multiple system atrophy
  194. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the assessment of the health risks of feeding of ruminants with fishmeal in relation to the risk of TSE
  195. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the request for review of the opinion on microbiological risks in infant formulae and follow-on formulae with regard to Enterobacteriaceae as indicators
  196. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms
  197. Synucleinopathy with features of both multiple system atrophy and dementia with Lewy bodies
  198. Brain Protein Preservation Largely Depends on the Postmortem Storage Temperature
  199. How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II
  200. TPPP/p25 in brain tumours: expression in non-neoplastic oligodendrocytes but not in oligodendroglioma cells
  201. The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases
  202. Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993–2002
  203. Opinion of the Scientific Panel on Biological Hazards (BIOHAZ) and of the Scientific Panel on Animal Health and Welfare (AHAW) on “Review of the Community Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Antimicrobial Resistance in th
  204. Histopathological prognostic factors in medulloblastoma: High expression of survivin is related to unfavourable outcome
  205. Immunohistochemical Analysis of INI1 Protein in Malignant Pediatric CNS Tumors: Lack of INI1 in Atypical Teratoid/Rhabdoid Tumors and in a Fraction of Primitive Neuroectodermal Tumors without Rhabdoid Phenotype
  206. Guidance document on the submission of data for the evaluation of the safety and the efficacy of substances for the removal of microbial surface contamination of foods of animal origin from the Scientific Panels AFC/BIOHAZ
  207. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease
  208. Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium
  209. Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue
  210. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the Breeding programme for TSE resistance in sheep
  211. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the safety of a Thermo-Mechanical Process to Convert Category 2 and 3 Animal By-Products (ABPs) into Bio-Fuel
  212. P3-198
  213. P4-152
  214. Immunohistochemical Expression of Prion Protein (PrPC) in the Human Forebrain During Development
  215. Prominent corticosteroid disturbance in experimental prion disease
  216. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein
  217. Introduction
  218. The Austrian FFI Cases
  219. Neuronal Apoptosis in Fatal Familial Insomnia
  220. Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes
  221. Immunohistochemistry for the Prion Protein: Comparison of Different Monoclonal Antibodies in Human Prion Disease Subtypes
  222. Opinion of the Scientific Panel on biological hazards (BIOHAZ) related to the public health risks of feeding farmed animals with ready‐to‐use dairy products without further treatment
  223. Opinion of the Scientific Panel on biological hazards (BIOHAZ) related to the evaluation of the efficacy of SAN‐PEL® for use as an antimicrobial substance applied on carcasses of chickens, turkeys, quails, pigs, beef, sheep, goats and game and in washi...
  224. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the evaluation of the efficacy of L (+) Lactic acid for carcass decontamination
  225. Endoplasmic Reticulum Stress Features Are Prominent in Alzheimer Disease but Not in Prion Diseases In Vivo
  226. Opinion of the Scientific Panel on Animal Health and Welfare (AHAW) on a request from the Commission related with the welfare aspects of the main systems of stunning and killing applied to commercially farmed deer, goats, rabbits, ostriches, ducks, geese
  227. UPDATE ON TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
  228. Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology
  229. Prions in Humans and Animals
  230. Upregulated Expression of 14-3-3 Proteins in Astrocytes From Human Cerebrovascular Ischemic Lesions
  231. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on “Evaluation of the efficacy of peroxyacids for use as an antimicrobial substance applied on poultry carcasses”
  232. Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma
  233. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the “Request for an opinion on the feasibility of establishing Trichinella-free areas, and if feasible on the risk increase to public health of not examining pigs from those areas for Trich
  234. Survivin Expression in Intracranial Ependymomas and Its Correlation With Tumor Cell Proliferation and Patient Outcome
  235. Genetic prion disease: the EUROCJD experience
  236. Immunohistochemical Analysis of Platelet-derived Growth Factor Receptor-α, -β, c-kit, c-abl, and Arg Proteins in Glioblastoma: Possible Implications for Patient Selection for Imatinib Mesylate Therapy
  237. Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity
  238. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the “Quantitative risk assessment of the animal BSE risk posed by meat and bone meal with respect to the residual BSE risk”
  239. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on vis-à-vis biological risks of biogas and compost treatment standards of animal by-products (ABP)
  240. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the biological safety of heat treatment of manure
  241. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the on the “Assessment of the human and animal BSE risk posed by tallow with respect to residual BSE risk”
  242. Pleomorphic xanthoastrocytoma with anaplastic features presenting without GFAP immunoreactivity: Implications for differential diagnosis
  243. Redox metals and oxidative abnormalities in human prion diseases
  244. The ubiquitin–proteasome system in Creutzfeldt–Jakob and Alzheimer disease: Intracellular redistribution of components correlates with neuronal vulnerability
  245. Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting
  246. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the α-galactosidase A gene
  247. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on: “A quantitative assessment of risk posed to humans by tissues of small ruminants in case BSE is present in these animal populations”
  248. UPDATE ON THE PATHOGENESIS OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
  249. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada
  250. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the assessment of the age limit in cattle for the removal of certain Specified Risk Materials (SRM)
  251. Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the risk assessment of a revised inspection of slaughter animals in areas with low prevalence of Cysticercus
  252. Viral encephalitis: a review of diagnostic methods and guidelines for management
  253. No prognostic impact of survivin expression in glioblastoma
  254. Pathogenesis of prion diseases
  255. Imaging ex vivo healthy and pathological human brain tissue with ultra-high-resolution optical coherence tomography
  256. Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival
  257. Presence of D110 antigen expressing immunocompetent cells in glioblastoma associates with prolonged survival
  258. Neuropathology of white matter disease in Leber's hereditary optic neuropathy
  259. Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies
  260. The prion protein in human neuromuscular diseases
  261. 14-3-3 proteins in Lewy body-like hyaline inclusions in patients with sporadic amyotrophic lateral sclerosis
  262. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies
  263. Concern about Mad Cow Disease: End of the beginning, or beginning of the end?
  264. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains
  265. Ki-67 Immunolabeling Index Is an Accurate Predictor of Outcome in Patients With Intracranial Ependymoma
  266. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors
  267. Standards for the assay of Creutzfeldt-Jakob disease specimens
  268. Meeting report
  269. Topographical and cytopathological lesion analysis of the white matter in Binswanger?s disease brains
  270. Advances in broad bandwidth light sources for ultrahigh resolution optical coherence tomography
  271. Complement activation in human prion disease
  272. Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis
  273. Antigenic profile of human recombinant PrP: generation and characterization of a versatile polyclonal antiserum
  274. Rationale for diagnosing human prion disease
  275. Creutzfeldt-Jakob disease and inclusion body myositis: Abundant disease-associated prion protein in muscle
  276. Rosette-forming glioneuronal tumor of the fourth ventricle
  277. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome
  278. Fluorescent In Situ Hybridization on Isolated Tumor Cell Nuclei: A Sensitive Method for 1p and 19q Deletion Analysis in Paraffin-Embedded Oligodendroglial Tumor Specimens
  279. D18G Transthyretin Is Monomeric, Aggregation Prone, and Not Detectable in Plasma and Cerebrospinal Fluid:  A Prescription for Central Nervous System Amyloidosis?†
  280. Molecular classification of sporadic Creutzfeldt–Jakob disease
  281. Neuropathology of prion diseases
  282. Immunostaining for ubiquitin: efficient pretreatment
  283. Severe depletion of mitochondrial DNA in spinal muscular atrophy
  284. Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease
  285. Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders
  286. The cerebral cortex in Fetal Down Syndrome
  287. A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans
  288. Disease-Associated Prion Protein in Vessel Walls
  289. Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy
  290. Mutations of the Prion Protein Gene
  291. The prion protein in human neurodegenerative disorders
  292. Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases
  293. Spontaneous mutations in the prion protein gene causing transmissible spongiform encephalopathy
  294. High expression of DNA topoisomerase IIα and Ki-67 antigen is associated with prolonged survival in glioblastoma patients
  295. Prognostic relevance of p53 protein expression in glioblastoma
  296. BSE and variant Creutzfeldt-Jakob disease: never say never
  297. Author reply to previously published correspondence
  298. Author reply
  299. Oxidative Damage to Nucleic Acids in Human Prion Disease
  300. Aging, the brain and human prion disease
  301. 14-3-3 Proteins in Lewy Bodies in Parkinson Disease and Diffuse Lewy Body Disease Brains
  302. Fibrous meningeal tumours with extensive non-calcifying collagenous whorls and glial fibrillary acidic protein expression: the whorling-sclerosing variant of meningioma
  303. DNA topoisomerase IIα expression in optic pathway gliomas of childhood
  304. Prominent Stress Response of Purkinje Cells in Creutzfeldt–Jakob Disease
  305. Increased incidence of sporadic Creutzfeldt‐Jakob disease on the island of Crete associated with a high rate of PRNP 129‐methionine homozygosity in the local population
  306. Expression of hypoxia-inducible factor-1α in oligodendrogliomas
  307. Inherited prion disease with A117V mutation of the prion protein gene: a novel Hungarian family
  308. Immunohistochemical Detection of Cell Growth Fraction in Formalin-Fixed and Paraffin-Embedded Murine Tissue
  309. Fibroblasts Can Express Glial Fibrillary Acidic protein (GFAP) In Vivo
  310. Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases
  311. Serotonergic nuclei of the raphe are not affected in human ageing
  312. Nail-Patella Syndrome Associated with Respiratory Chain Disorder
  313. Reply
  314. Dysembryoplastic Neuroectodermal Tumor: An Ultrastructural Study of Six Cases
  315. Increased incidence of sporadic Creutzfeldt-Jakob disease on the island of Crete associated with a high rate ofPRNP 129-methionine homozygosity in the local population
  316. Alteration of the serotonergic nervous system in fatal familial insomnia
  317. Alteration of the serotonergic nervous system in fatal familial insomnia
  318. Binswanger's encephalopathy: serial sections and morphometry of the cerebral arteries
  319. Kynurenic acid metabolism in the brain of HIV-1 infected patients
  320. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease
  321. Neuropathological relationships between Austria and Japan
  322. No tissue damage by chronic deep brain stimulation in Parkinson's disease
  323. Evidence for Oxidative Stress in Experimental Prion Disease
  324. Vascular Cell Components of the Medullary Arteries in Binswanger’s Disease Brains
  325. Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans
  326. An autosomal dominant early adult-onset distal muscular dystrophy
  327. Deposition of the prion protein (PrP) during the evolution of experimental Creutzfeldt-Jakob disease
  328. Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie
  329. Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies
  330. Selective Neuronal Vulnerability in Human Prion Diseases
  331. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects
  332. Early Destruction of the Extracellular Matrix around Parvalbumin-Immunoreactive Interneurons in Creutzfeldt-Jakob Disease
  333. Vascular changes in white matter lesions of Alzheimer's disease
  334. A novel phenotype in familial Creutzfeldt-Jakob disease: Prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein
  335. IMMUNOCYTOCHEMICAL DETECTION OF DISEASE-ASSOCIATED PRION PROTEIN IN THE PERIPHERAL NERVOUS SYSTEM OF PRION DISEASE
  336. Neuroaxonal pathology in Creutzfeldt-Jakob disease
  337. Ancestral Origins and Worldwide Distribution of the PRNP 200K Mutation Causing Familial Creutzfeldt-Jakob Disease
  338. Cytopathological alterations and therapeutic approaches in Binswanger's disease
  339. Fatal familial insomnia: a new Austrian family
  340. Development of HIV encephalitis in AIDS and TNF-α regulatory elements
  341. Severe, Early and Selective Loss of a Subpopulation of GABAergic Inhibitory Neurons in Experimental Transmissible Spongiform Encephalopathies
  342. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease
  343. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann–Sträussler–Scheinker disease
  344. Virus production, cell proliferation and cell death in progressive multifocal leukoencephalopathy
  345. NEURONAL APOPTOSIS IN HUMAN PRION DISEASES
  346. SELECTIVE, SEVERE AND EARLY LOSS OF A SUBSET OF INHIBITORY NEURONS IN EXPERIMENTAL TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
  347. Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study
  348. Malnutrition-Induced Hypokalemic Myopathy in Chronic Alcoholism
  349. Metallothionein overexpression in human brain tumours
  350. Encephalitogenic peptide (EP) in human cerebrovascular white matter lesions
  351. Proliferation and Dna fragmentation in meningioma subtypes
  352. Absence of measles virus receptor (CD46) in lesions of subacute sclerosing panencephalitis brains
  353. The human prion diseases: from neuropathology to pathobiology and molecular genetics
  354. Ganglionitis in paraneoplastic subacute sensory neuronopathy: A morphologic study
  355. Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI
  356. Alterations in Glia and Axons in the Brains of Binswanger’s Disease Patients
  357. The human prion disease—from neuropathology to pathobiology and molecular genetics: an update
  358. Central nervous system pathology in patients with the Guillain-Barre syndrome
  359. Non-HTLV-I associated pleomorphic T-cell lymphoma of the brain mimicking post-vaccinal acute inflammatory demyelination
  360. Naturally Occurring Herpes Simplex Encephalitis in a Domestic Rabbit (Oryctolagus cuniculus)
  361. Pathology and Immunocytochemistry of a Kuru Brain
  362. Primary Neuroendocrine (Merkel Cell) Carcinoma of the Anterior Skull Base
  363. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly)
  364. Phenotypic variation in Creutzfeldt-Jakob disease, May 31 and June 1, 1996, Vienna, Austria
  365. Creutzfeldt-Jakob disease in Austria.
  366. T Cell-mediated ganglionitis associated with acute sensory neuronopathy
  367. Reply
  368. Testing for prion protein does not confirm previously reported conjugal CJD
  369. Subacute measles virus encephalitis: A new and fatal opportunistic infection in a patient with AIDS
  370. HIV and brain pathology: where do we go from here?
  371. Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions
  372. Suprasellar meningioma with expression of glial fibrillary acidic protein: a peculiar variant
  373. Neuropathological Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases)
  374. Diagnostic value of stereotactic biopsy of cerebral lesions in patients with AIDS
  375. Tissue Handling in Suspected Creutzfeldt-Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases)
  376. The Original Gerstmann-Sträussler-Scheinker Family of Austria: Divergent Clinicopathological Phenotypes but Constant PrP Genotype
  377. Trilobar holoprosencephaly ("triprosencephaly"): a unique type of cerebral malformation
  378. Neuroaxonal dystrophy in experimental creutzfeldt-jakob disease: Electron microscopical and immunohistochemical demonstration of neurofilament accumulations within affected neurites
  379. Sensory Neuropathies
  380. Diffuse Lewy body disease as substrate of primary lateral sclerosis
  381. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence
  382. Ultra Structural Pathology of Gerstmann-Sträussler-Scheinker Disease
  383. Lipomatous medulloblastoma in adults: A new tumor type with possible favorable prognosis
  384. Tubulovesicular structures in Gerstmann-Str�ussler-Scheinker disease
  385. Patterns of oligodendroglia pathology in multiple sclerosis
  386. Symposia on Neurodegenerative Disorders: Common Molecular Mechanisms, Ocho Rios, Jamaica, February 1993 * and April 1994
  387. Clonal Expansion of Hypermutated Measles Virus in a SSPE Brain
  388. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens
  389. Astroglial changes in the cerebral cortex of AIDS brains: a morphometric and immunohistochemical investigation
  390. Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Str�ussler-Scheinker syndrome
  391. Fatal Encephalitis Caused by Concomitant Infection with Tick-Borne Encephalitis Virus and Borrelia burgdorferi
  392. Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study
  393. Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis
  394. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance
  395. Morphological spectrum, distribution and clinical correlation of white matter lesions in AIDS brains
  396. Subacute diencephalic angioencephalopathy: an entity similar to angiodysgenetic necrotizing encephalopathy and Foix-Alajouanine disease
  397. PRESENCE, DISTRIBUTION AND SPREAD OF PRODUCTIVE VARICELLA ZOSTER VIRUS INFECTION IN NERVOUS TISSUES
  398. Tubulovesicular structures in human and experimental Creutzfeldt-Jakob disease
  399. Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy
  400. MEETING REPORT
  401. Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker
  402. Neuropathology of Human Immunodeficiency Virus Infection
  403. HIV-Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology-Based Terminology
  404. HIV-lnduced CNS Lesions
  405. The Definition of HIV-specific Neuropathology
  406. Lipomatous differentiation in a medulloblastoma
  407. Determination of proliferative activities in human brain tumor specimens: a comparison of three methods
  408. Multifocal vacuolar leucoencephalopathy: a distinct HIV-associated lesion of the brain
  409. Progressive multifocal leukoencephalopathy (PML) in AIDS and in the pre-AIDS era
  410. Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation
  411. Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignany and proliferation indices
  412. Loss of neurons in the frontal cortex in AIDS brains
  413. Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS)
  414. Cytomegalovirus (CMV) disease of the brain in AIDS and connatal infection: a comparative study by histology, immunocytochemistry and in situ DNA hybridization
  415. Herpes Simplex Virus (HSV) DNA in Microglial Nodular Brainstem Encephalitis
  416. Neuropathology of dementia
  417. CNS DISTRIBUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIGENS IN AIDS
  418. Letter to the case
  419. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease
  420. An Antigenic Profile of Lewy Bodies: Immunocytochemical Indication for Protein Phosphorylation and Ubiquitination
  421. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis
  422. In situ analysis of cell kinetics in human brain tumors
  423. Vacuolar myelopathy with multinucleated giant cells in the acquired immune deficiency syndrome (AIDS)
  424. Human Immunodeficiency Virus in Vacuolar Myelopathy of the Acquired Immunodeficiency Syndrome
  425. Neuropathy Associated with Acrodermatitis Chronica Atrophicans Clinical and Morphological Features
  426. NIMODIPINE DOES NOT REDUCE BRAIN DAMAGE AFTER VENTRICULAR FIBRILLATION IN AN ACUTE PIG MODEL
  427. Comparison of in situ DNA hybridization (ISH) and immunocytochemistry for diagnosis of herpes simplex virus (HSV) encephalitis in tissue
  428. Human Immunodeficiency Virus in Glial Cells?
  429. Glioblastoma developing at the site of a cerebellar medulloblastoma treated 6 years earlier
  430. Pathogenesis of HIV-associated brain lesions: A neuropathological evaluation
  431. Brain pathology induced by infection with the human immunodeficiency virus (HIV)
  432. Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences
  433. Contribution of histiocytic cells to sarcomatous development of the gliosarcoma
  434. Restricted Expression of Measles Virus Proteins in Brains from Cases of Subacute Sclerosing Panencephalitis
  435. Unilateral Creutzfeldt-Jakob disease
  436. Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: Immunocytochemical demonstration of dissociation of two glia-associated proteins
  437. Development of stroma in malignant lymphomas of the brain compared with epidural lymphomas
  438. Multinucleated giant cells in brain: A hallmark of the acquired immune deficiency syndrome (AIDS)
  439. Non-glial specificities of immunocytochemistry for the glial fibrillary acidic protein (GFAP)
  440. Cross-reactivity of human brain tumors with lymphoid- and hemapoietic-associated monoclonal antibodies
  441. Cross-reactivity between human hemopoietic cells and brain tumors as defined by monoclonal antibodies
  442. Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS)
  443. Occurrence of IgA Subclasses (IgA1 and IgA2) in the Human Nervous System
  444. Shared antigenic determinants between human hemopoietic cells and nervous tissues and tumors
  445. 23 MONOCLONAL ANTIBODIES RAISED AGAINST HEMOPOIETIC CELLS
  446. Glial bundles in spinal nerve roots
  447. Tumoren des Zentralnervensystems
  448. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: Gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma
  449. Production of glial fibrillary acidic protein (GFAP) by neoplastic cells: Adaptation to the microenvironment
  450. Auge und seine Anhangsgebilde
  451. Immunohistological Demonstration of Serum Proteins and Structural and Viral Antigens in Paraffin Sections of Nervous Tissues
  452. Supratentorial lobar ependymomas: Reports on the grading and survival periods in 80 cases, including 46 recurrences
  453. Brain tissue immunoglobulins in adrenoleukodystrophy: A comparison with multiple sclerosis and systemic lupus erythematosus
  454. PAPOVA VIRAL ANTIGENS IN PML BRAINS
  455. Hyaline inclusions (pseudopsammoma bodies) in meningiomas: Immunocytochemical demonstration of epithel-like secretion of secretory component and immunoglobulins A and M
  456. Measles virus antigen in panencephalitis
  457. Accumulation of very long chain fatty acids is common to 3 variants of adrenoleukodystrophy (ALD)
  458. Brain Pathology in the Collagen Vascular Diseases
  459. Inflammatory Demyelinating Polyradiculitis in a Patient With Multiple Sclerosis
  460. Rabies and Herpes simplex virus encephalitis
  461. Benign mixed glial-mesenchymal tumour (“glio-fibroma”) of the spinal cord
  462. Diagnostic and pathomorphological aspects of glioma multiplicity
  463. Hereditary cerebellar atrophy (Holmes type) with optic atrophy
  464. Intermittent meningitic reaction with severe basophilia and eosinophilia in CNS leukaemia
  465. Spastic paraplegia associated with addison's disease: Adult variant of adreno-leukodystrophy
  466. Primary leptomeningeal sarcomatosis
  467. Partially resected und irradiated cerebellar astrocytoma of childhood: Malignant evolution after 28 years
  468. Primary glioblastoma of the cerebellum
  469. Addendum
  470. Intracranial lipomatous hamartomas (Intracranial ?lipomas?)
  471. Liquorzellbefunde bei primärer diffuser Melanoblastose der Meningen
  472. Über Ringschlußreaktionen bei Stickstoffheterocyclen, II. Mitteil.: Cyclisierung von N‐Cyan‐N‐[ω‐cyan‐n‐hexyl]‐anilin nach dem Ziegler‐Ringschlußverfahren
  473. Tubulovesicular structures are consistently found in prion diseases including vCJD and FFI
  474. Central Pathogenesis of Prion Diseases